跳至主要内容
临床试验/NCT02096835
NCT02096835已完成不适用

Transcutaneous Electrical Acupoint P6 Stimulation vs. Tropisetron Both in Combination With Dexamethasone to Prevent Postoperation Nausea and Vomiting in Women

Huashan Hospital1 个研究点 分布在 1 个国家目标入组 157 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
157
试验地点
1
主要终点
Number of Participants Experiencing Postoperative Nausea and Vomiting in 24h Postoperatively

研究概览

简要总结

The purpose of this study is to access the effect of TEAS of P6 in the prevention of PONV in women scheduled for gynecologic laparoscopic surgery with general anesthesia.

详细描述

150 female patients, aged between 18 to 60 y, who are scheduled for elective gynecological laparoscopic surgery requiring general anesthesia, will be randomly allocated by a computer generated randomization table to acustimulation group (Group Acu), tropisetron group (Group Trp),or dexamethasone group (Group Dxm).

In Group Acu, a surface electrode will be applied in the induction room to the P6 acupoint 30 min before induction.An operator will set electric stimulating current at 1mA with frequency at 2 Hz, and gradually increased the current intensity to a little below discomfort threshold.The stimulation will be maintained until the patient is discharged from the post-anesthesia care unit (PACU). In Group Trp and Group Dxm, the same protocol will be applied unless silicone covers attached to both electrodes.

A standardized anesthetic protocol will be followed. After induction, dexamethasone 10mg i.v. will be given in all groups. All patients will receive intravenous lactated Ringer's solution based on calculated preoperative deficits, surgical procedure, and estimated intraoperative blood loss. Parecoxib 40mg i.v. during surgery and incision infiltration of 0.5% ropivacaine at the end of surgery will be used for post-operative analgesia. After surgery, analgetic therapy will continue with morphine upon patient's request.After extubation, patients will be transported to PACU and observed for no less than 30 min. Metoclopramide 10mg i.v. will be administered as a rescue therapy to any patient who experiences an episode of moderate or severe nausea, an episode of vomiting, and requests rescue medication.

At the start of skin closure, a prefilled syringe which contains 5 ml of a solution will be administered intravenously to the patient. It will contain either saline (Group Acu and Group Dxm) or tropisetron 5mg (Group Trp).The syringe with the drug will be prepared by a study coordinator according to group allocation.

The patients, the anesthesiologists, and the nursing staff shall be unaware of the group assignments.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • American Society of Anesthesiologists (ASA) physical status I or II
  • aged between 18 to 60yr
  • scheduled for elective gynecological laparoscopic surgery requiring general anesthesia

排除标准

  • pregnancy or breastfeeding
  • mental retardation
  • psychiatric or neurological disease
  • use of antiemetics, emetogenic drugs, opioids or glucocorticosteroids within 3 days prior to surgery
  • known allergy to tropisetron or dexamethasone
  • nausea and/or vomiting within 24 hr prior to surgery
  • implantation of a cardiac pacemaker, cardioverter, or defibrillator
  • any skin problem at the acupoint stimulation area

研究组 & 干预措施

Acustimulation

Experimental

Transcutaneous electrical acupoint stimulation (TEAS) starts 30 min before surgery and lasts until patient leaves the postanesthetic care unit.Dexamethasone 10mg i.v. after induction.

干预措施: Transcutaneous electrical acupoint stimulation (Device)

Acustimulation

Experimental

Transcutaneous electrical acupoint stimulation (TEAS) starts 30 min before surgery and lasts until patient leaves the postanesthetic care unit.Dexamethasone 10mg i.v. after induction.

干预措施: Dexamethasone (Drug)

Tropisetron

Active Comparator

Tropisetron 5mg iv. at the start of skin closure.Sham transcutaneous electrical acupoint stimulation.Dexamethasone 10mg i.v.after induction.

干预措施: Sham transcutaneous electrical acupoint stimulation (Device)

Tropisetron

Active Comparator

Tropisetron 5mg iv. at the start of skin closure.Sham transcutaneous electrical acupoint stimulation.Dexamethasone 10mg i.v.after induction.

干预措施: Tropisetron (Drug)

Tropisetron

Active Comparator

Tropisetron 5mg iv. at the start of skin closure.Sham transcutaneous electrical acupoint stimulation.Dexamethasone 10mg i.v.after induction.

干预措施: Dexamethasone (Drug)

Control

Sham Comparator

Sham transcutaneous electrical acupoint stimulation. Dexamethasone 10mg i.v.after induction.

干预措施: Sham transcutaneous electrical acupoint stimulation (Device)

Control

Sham Comparator

Sham transcutaneous electrical acupoint stimulation. Dexamethasone 10mg i.v.after induction.

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Number of Participants Experiencing Postoperative Nausea and Vomiting in 24h Postoperatively

时间窗: within 24h after operation

the total number including nausea, retching and vomiting within 24h after operation

次要结局

  • Number of Participants Experiencing Postoperative Nausea in 24h Postoperatively(within 24h after the operation)
  • Number of Participants Experiencing Postoperative Vomiting in 24h Postoperatively(within 24h after operation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiao-Yu Yang, MD

MD.

Huashan Hospital

研究点 (1)

Loading locations...

相似试验